MIMOSAPHARMA
ActiveSummary
MIMOSAPHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,738 and a net result of €24,738. Its solvency ranks better than 95% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Group and network
Connections & network
No sitting directors or connected companies in the Gazette act read.